WALD - Earnings announcements

FY 2025 net revenue of $272.1 million, flat to FY 2024, and Adjusted EBITDA of $16.1 million Q4 2025 net revenue of $72.0 million, flat to Q4 2024 and Adjusted EBITDA of $6.6 million Obagi Medical sees continued revenue acceleration as a result of transformation efforts and continued brand momentum, alongside investments supporting the recent launch of its injectables platform Milk Makeup maintains U.S. consumption growth through distribution expansion, offset by softness in international markets Waldencast advanced its strategic priorities in 2025, entering medical aesthetics, and strengthening its financial flexibility through the sale of the Obagi Japan trademark and the refinancing o

LONDON, March 11, 2026 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform announced that its Fourth Quarter and Fiscal Year 2025 earnings will be issued in a press release on March 13, 2026, prior to U.S. market open. The Company does not plan to host a conference call to discuss results given its ongoing strategic review. About Waldencast plc Founded by Michel Brousset and Hind Sebti, Waldencast's ambition is to build a global best-in-class beauty and wellness operating platform by developing, acquiring, accelerating, and scaling conscious, high-growth purpose-driven brands. Waldencast's vision is fundamentally underpinned

Transformation efforts drive performance improvements at Obagi Medical with accelerating revenue Contrasted performance for Milk Makeup with Q2 2025 net revenue growth driven by U.S. channel expansion and sell-out acceleration but softer performance in Q3 2025 in international markets Company advances key strategic initiatives, including expansion into medical aesthetics through the Novaestiq acquisition and strengthened balance sheet following the sale of the Obagi Japan trademark and credit facility refinancing Waldencast updates FY 2025 guidance to reflect current trends and purposeful investments to drive long-term growth LONDON, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NA

LONDON, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, provided additional details for its upcoming earnings release and conference call dates. The Company currently expects to issue Second Quarter Fiscal 2025 Results and Q3 2025 Financial Results on November 24, 2025. The Company does not plan to host a conference call with respect to these results given its ongoing strategic review. About Waldencast plc Founded by Michel Brousset and Hind Sebti, Waldencast's ambition is to build a global best-in-class beauty and wellness operating platform by developing, acquiring, accelerating, and scaling conscious, h

Obagi Medical delivers H1 2025 double-digit growth in its Core Strategic Channels. Novaestiq Acquisition Doubles the Brand's Addressable Market in the U.S. Milk Makeup Delivers Strong Retail Sales Performance in U.S. Retail in H1 2025 and Expands Its Digital Footprint in Q2 Company Launches an Exploration of Strategic Alternatives to Enhance Shareholder Value Company Postpones H1 2025 Earnings Release and Conference Call; Provides Update to FY 2025 Guidance LONDON, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today provided a business update for H1 2025 results. "Our brands

Q1 Net Revenue of $65.4 million, (4.1)% decline from Q1 202476.4% Adjusted Gross Margin, an improvement of 10 basis points$4.4 million of Adjusted EBITDA LONDON, May 13, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today reported operating results for the three months ended March 31, 2025 ("Q1 2025") on Form 6-K to the U.S. Securities and Exchange Commission (the "SEC"), which are also available on our investor relations site at http://ir.waldencast.com/. Michel Brousset, Waldencast Founder and CEO, said: "As anticipated, in Q1 2025, Milk Makeup results were impacted by the cycling of the very su

LONDON, May 06, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform provided the details for its First Quarter Fiscal 2025 conference call and webcast. As previously announced, the Company will issue its First Quarter Fiscal 2025 results on May 13, 2025 after the close of the U.S. market. Management will host a conference call to discuss its First Quarter Fiscal 2025 results on May 14, 2025 at 8:30am ET. Investors and analysts interested in participating in the conference call are invited to dial (877) 704-4453 or (201) 389-0920 for international callers. The conference call will be webcast live and include a slide p

Q4 Net Revenue of $72.1 million, 29.4% Comparable Net Revenue Growth and $11.2 million of Adjusted EBITDA, doubling from Q4 2023 FY 2024 Net Revenue of $273.9 million, 27.5% Comparable Net Revenue Growth and $40.3 million of Adjusted EBITDA Obagi Medical is the fastest growing professional skincare brand1 in the US in 2024 Milk Makeup expands its distribution to Ulta Beauty Waldencast secures a new $205 million credit facility, replacing the current one, enhancing flexibility and extending debt maturity LONDON, March 18, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today reported operating res

LONDON, March 11, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform provided the details for its Fourth Quarter and Fiscal Year 2024 conference call and webcast. As previously announced, the Company will issue its Fourth Quarter and Fiscal Year 2024 results on March 18, 2025 after the close of the U.S. market. Management will host a conference call to discuss its Fourth Quarter and Fiscal Year 2024 results on March 19, 2025 at 8:30am ET. Investors and analysts interested in participating in the conference call are invited to dial (877) 704-4453 or (201) 389-0920 for international callers. The conference call will be we

LONDON, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, announced upcoming earnings release, conference call and webcast information for the fourth quarter and full fiscal year 2024 and first, second, and third quarters of fiscal year 2025. The webcasts will be available on the Investor Relations page on the company's website at https://ir.waldencast.com/ approximately 2 weeks prior to the events. For the fourth quarter and full fiscal year 2024, the Company plans to issue a press release detailing its financial performance after the U.S. stock market closes on Tuesday, March 18th, 2025. The Company's manag

$70.2 million of Net Revenue Q3 2024+34.6% Comparable Net Revenue GrowthBoth brands accelerating from Q2 2024+45.5% Obagi Medical and +23.5% Milk Makeup vs Q3 2023Adjusted EBITDA of $11.4 million, up +134.0% vs Q3 2023 LONDON, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today reported operating results for the three months ended September 30, 2024 ("Q3 2024") and nine months ended September 30, 2024 ("Nine Months 2024") on Form 6-K to the U.S. Securities and Exchange Commission, which are also available on the Company's investor relations site at http://ir.waldencast.com/. Michel Brouss

LONDON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform provided the details for its Third Quarter Fiscal 2024 conference call and webcast. As previously announced, the Company will issue its Third Quarter Fiscal 2024 results on November 20, 2024 after the close of the U.S. market. Management will host a conference call to discuss its Third Quarter Fiscal 2024 results on November 21, 2024 at 8:30am ET.   Investors and analysts interested in participating in the conference call are invited to dial (877) 704-4453 or (201) 389-0920 for international callers. The conference call will be webcast live and include

$63.3 million of Net Revenue Q2 2024 +25.7% net revenue Comparable Growth: +30.9% Obagi Medical and +20.0% Milk Makeup vs Q2 2023 Adjusted EBITDA of $6.3 million, up +64.5% vs Q2 2023 NEW YORK, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today reported operating results for the three months ended June 30, 2024 ("Q2 2024") and six months ended June 30, 2024 ("H1 2024") on Form 6-K to the U.S. Securities and Exchange Commission, which are also available on the Company's investor relations site at http://ir.waldencast.com/. Michel Brousset, Waldencast Founder and CEO, said: "We

NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, provided second quarter and first half fiscal 2024 earnings conference call and webcast information. As previously announced, the Company will report second quarter and first half fiscal 2024 earnings on August 27th, after the close of the U.S. stock market. The Company will conduct a conference call to discuss its earnings results on Wednesday, August 28, 2024 at 8:30am ET. Investors and analysts interested in participating in the conference call are invited to dial (877) 704-4453 or (201) 389-0920 for international callers. The conference call wi

WHITE PLAINS, N.Y., June 27, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, announced upcoming earnings release, conference call and webcast dates. On Tuesday, August 27, 2024, after the U.S. stock market closes, the Company plans to issue a press release detailing its financial performance for the second quarter and first half of fiscal 2024. The Company's management team will conduct a conference call and webcast with slide presentation to discuss its results, strategy and outlook on Wednesday, August 28, 2024 at 8:30am ET. On Wednesday, November 20, 2024, after the U.S. stock market closes, the Company plans to

$68.3 million of Net Revenue+21.0% Comparable Net Revenue: +20.6% Obagi Skincare and +21.5% Milk MakeupAdjusted EBITDA of $11.4 million, up +12.9% vs Q1 2023 WHITE PLAINS, N.Y., May 21, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today reported operating results for the quarter ended March 31, 2024 ("Q1 2024 Financials") on Form 6-K to the U.S. Securities and Exchange Commission, which are also available on the Company's investor relations site at http://ir.waldencast.com/.  Michel Brousset, Waldencast Founder and CEO, said: "We had a strong start to the year, growing 21.0% in Comparable Net Rev

NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, announced that it will release its first quarter fiscal 2024 earnings results before the U.S. stock market opens on Tuesday, May 21, 2024. The Company will conduct a conference call to discuss its earnings results on the same day at 8:30am ET. Investors and analysts interested in participating in the conference call are invited to dial (877) 704-4453 or (201) 389-0920 for international callers. The conference call will be webcast live and can be accessed at https://ir.waldencast.com/. A replay of the webcast will remain available on the website for 90

—  H1'23 Total Net Revenue of $109.3 million—  H1'23 Combined Adjusted EBITDA of $13.9 million up from $7.6 million in H1'22—  Introduces guidance WHITE PLAINS, N.Y., March 20, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today announced that it furnished its results for the interim period ended June 30, 2023 ("H1 2023 Interim Financials") on Form 6-K to the U.S. Securities and Exchange Commission, which are also available on the Company's investor relations site at http://ir.waldencast.com/. Michel Brousset, Waldencast Founder and CEO, said: "2023 was a year of transition during which we acc

Acquisition to Accelerate Strategic Growth in a Key Skincare Market Company Moves Fourth Quarter Fiscal 2022 Earnings Call to April 26, 2023 NEW YORK, March 13, 2023 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, announced today that it signed a binding letter of intent to acquire a 60% controlling interest in a newly formed entity to be comprised of the business of its Southeast Asia (SEA) distributor. The letter of intent is binding upon the SEA distributor, but Waldencast's obligations are subject to the satisfaction of certain conditions. Assuming the satisfactory completion of its due diligence and negotiation of

NEW YORK, March 08, 2023 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, today announced that it will hold a conference call to discuss its fourth quarter 2022 earnings results on Wednesday, March 15, 2023 at 8:30am ET. The fourth quarter 2022 earnings press release will be issued prior to the start of the call. Investors and analysts interested in participating in the conference call are invited to dial (833) 630-1956 or (412) 317-1837 for a toll-free number. The conference call will be webcast live and can be accessed at https://ir.waldencast.com/. A replay of the webcast will remain available on the website for 90 day

Q3 2022 Net Sales of $78.9 millionQ3 2022 Gross margin of 62.4% and adjusted gross margin of 71.9%Q3 2022 Net loss of $16.8 millionQ3 2022 Adjusted EBITDA of $15.3 million, or 19.4% of net salesCompany reaffirms guidance NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, today announced results for the third quarter ended September 30, 2022. Michel Brousset, Waldencast Founder and CEO, said: "We are pleased with our third quarter performance, which continued the positive momentum for our brands from the first half of the year, highlighted by increased sales and profitability. We are excited about ou

NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, today announced that it will hold a conference call to discuss its third quarter 2022 earnings results on Thursday, November 10, 2022 at 8:30am ET. The third quarter 2022 earnings press release will be issued prior to the start of the call. Investors and analysts interested in participating in the conference call are invited to dial (646) 307-1963 or (800) 715-9871 for a toll-free number (conference ID: 6198725). The conference call will be webcast live and can be accessed at https://ir.waldencast.com/. A replay of the webcast will remain available o

-   1H 2022 Total Net Sales of $138.2 million, increasing 24.6% from 1H 2021-   1H 2022 Gross margin of 73.8%, up 294 bps from 1H 2021-   1H 2022 Pro Forma Adjusted EBITDA margin of 23.5% versus 22.8% in 1H 2021-   Q2 2022 Total Net Sales of $77.1 million, increasing 23.8% from Q2 2021-   Q2 2022 Gross margin of 75.1%, up 578 basis points from Q2 2021-   Q2 2022 Pro Forma Adjusted EBITDA margin of 28.4% versus 25.4% in Q2 2021-   Company Reaffirms Guidance NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, today announced results for the second quarter and first half of 2022. Michel Brousset, Walden

NEW YORK, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, today announced that it will hold a conference call to discuss its second quarter and first half 2022 earnings results on Thursday, August 11, 2022 at 8:00am ET. The second quarter and first half 2022 earnings press release will be issued prior to the start of the call. Investors and analysts interested in participating in the conference call are invited to dial (855) 327-6837 or (631) 891-4304 for international callers approximately ten minutes prior to the start of the call. The conference call will be webcast live and can be accessed at https://ir.